Impact of inhibitors on hemophilia a mortality in the United States

American Journal of Hematology

Volumn 90, Issue 5, 2015, Pages 400-405

  Walsh, Christopher E ^a   Soucie, J Michael ^b   Miller, Connie H ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTHROMBIN COMPLEX; BLOOD CLOTTING FACTOR 8 ANTIBODY; RECOMBINANT BLOOD CLOTTING FACTOR 7A; ANTIBODY; BLOOD CLOTTING FACTOR 8;

ADOLESCENT; ADULT; ANTIBODY TITER; ARTHRALGIA; ARTICLE; BLEEDING; BRAIN HEMORRHAGE; CAUSE OF DEATH; HEMOPHILIA A; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGICAL TOLERANCE; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAID; MEDICALLY UNINSURED; MEDICARE; MOTOR DYSFUNCTION; OBESITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SELF REPORT; UNITED STATES; WEAKNESS; ANTAGONISTS AND INHIBITORS; BLOOD; CHILD; COMPLICATION; CYTOMEGALOVIRUS INFECTIONS; HIV INFECTIONS; MIDDLE AGED; MORTALITY; RISK FACTOR; SURVIVAL;

ADOLESCENT; ADULT; ANTIBODIES; CHILD; CYTOMEGALOVIRUS INFECTIONS; FACTOR VIII; HEMOPHILIA A; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; UNITED STATES;

EID: 84928272570     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.23957     Document Type: Article

References (18)

1. Wight J, Paisley S. The epidemiology of inhibitors in haemophilia a: A systematic review. Haemophilia 2003;9:418-435.
2. Soucie JM, Miller CH, Kelly FM, et al. A study of prospective surveillance for inhibitors among persons with haemophilia in the United States. Haemophilia 2014;20:230-237.
3. Diamondstone LS, Aledort LM, Goedert JJ. Factors predictive of death among HIV-uninfected persons with haemophilia and other congenital coagulation disorders. Haemophilia 2002;8:660-667.
4. Ikkala E, Helske T, Myllyla G, et al. Changes in the life expectancy of patients with severe haemophilia a in Finland in 1930-79. Br J Haematol 1982;52:7-12.
5. Larsson SA, Wiechel B. Deaths in Swedish hemophiliacs, 1957-1980. Acta Med Scand 1983;214:199-206.
6. Rizza CR, Spooner RJ. Treatment of haemophilia and related disorders in Britain and northern Ireland during 1976-80: Report on behalf of the directors of haemophilia centres in the United Kingdom. Br Med J 1983;286:929-933.
7. Rosendaal FR, Varekamp I, Smit C, et al. Mortality and causes of death in Dutch haemophiliacs, 1973-86. Br J Haematol 1989;71:71-76.
8. Gouw SC, van der Bom JG, Marijke van den Berg H. Treatment-related risk factors of inhibitor development in previously untreated patients with hemophilia A: The CANAL cohort study. Blood 2007;109:4648-4654.
9. Rasi V, Ikkala E. Haemophiliacs with factor VIII inhibitors in Finland: Prevalence, incidence and outcome. Br J Haematol 1990;76:369-371.
10. Darby SC, Kan SW, Spooner RJ, et al. Mortality rates, life expectancy, and causes of death in people with hemophilia a or B in the united kingdom who were not infected with HIV. Blood 2007;110:815-825.
11. Darby SC, Keeling DM, Spooner RJ, et al. The incidence of factor VIII and factor IX inhibitors in the hemophilia population of the UK and their effect on subsequent mortality, 1977-99. J Thromb Haemost 2004;2:1047-1054.
12. Soucie JM, Nuss R, Evatt B, et al. Mortality among males with hemophilia: Relations with source of medical care. The hemophilia surveillance system project investigators. Blood 2000;96:437-442.
13. Leissinger C, Gringeri A, Antmen B, et al. Anti-inhibitor coagulant complex prophylaxis in hemophilia with inhibitors. N Engl J Med 2011;365:1684-1692.
14. Antunes SV, Tangada S, Stasyshyn O, et al. Randomized comparison of prophylaxis and on-demand regimens with FEIBA NF in the treatment of haemophilia a and B with inhibitors. Haemophilia 2014;20:65-72.
15. Soucie JM, McAlister S, McClellan A, et al. The universal data collection surveillance system for rare bleeding disorders. Am J Prev Med 2010;38:S475-S481.
16. Centers for Disease Control and Prevention. BMI-for-age growth charts for girls and boys. Available at: http://www.cdc.gov/healthyweight/assessing/bmi/childrens_bmi/about_childrens_bmi.html; last accessed 3/13/2014.
17. Shy C, Kleinbaum DG, Morgenstern H. The effect of misclassification of exposure status in epidemiologic studies of air pollution health effects. Bull N Y Acad Med 1978;54:1155-1165.
18. DiMichele DM. Immune tolerance in haemophilia: The long journey to the fork in the road. Br J Haematol 2012;159:123-134.